ホーム › 乳がん › カリフォルニア州 › Santa Monica
Santa Monica、CAにおける乳がんの臨床試験
Santa Monicaとその周辺地域（約30マイル以内）の拠点で、乳がんに関する29件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
被験者募集中第1/2相
- Research Facility, Santa Monica
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
被験者募集中第3相
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
被験者募集中第3相
- Beverly Hills Cancer Center, Beverly Hills · 6マイル先
A Study of PHST001 in Advanced Solid Tumors
被験者募集中第1相
- Precision NextGen Oncology & Research Center, Beverly Hills · 6マイル先
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
被験者募集中第2相
- Beverly Hills Cancer Center, Beverly Hills · 6マイル先
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
被験者募集中
- UCLA David Geffen School of Medicine, Santa Monica
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
被験者募集中第3相
- Clinical Trial Site, Beverly Hills · 6マイル先
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
被験者募集中第1相
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6マイル先
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
被験者募集中第2相
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
被験者募集中第1相
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
被験者募集中第1/2相
- Beverly Hills Cancer Center, Beverly Hills · 6マイル先
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6マイル先
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
被験者募集中第1/2相
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
被験者募集中第2相
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Tower Cancer Research Foundation, Beverly Hills · 6マイル先
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11マイル先
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12マイル先
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
被験者募集中第3相
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- 他1件
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
被験者募集中第1相
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6マイル先
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
被験者募集中第2相
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11マイル先
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
被験者募集中第3相
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
被験者募集中第3相
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12マイル先
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
被験者募集中第2相
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4マイル先
- Precision NextGen Oncology & Research Center, Beverly Hills · 6マイル先
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
被験者募集中第1/2相
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
被験者募集中第1相
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11マイル先
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
被験者募集中観察研究
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
他の都市における乳がんの試験
- New York City, NY137件の研究
- Houston, TX127件の研究
- Boston, MA113件の研究
- Nashville, TN80件の研究
- Los Angeles, CA72件の研究
- Edison, NJ67件の研究
- St. Louis, MO65件の研究
- Durham, NC64件の研究
- Queens, NY63件の研究
- Chicago, IL59件の研究
- Philadelphia, PA57件の研究
- Dallas, TX56件の研究
Santa Monicaにおける他の研究
- 非小細胞肺癌45件の研究
- 大腸癌23件の研究
- がん（全種類）22件の研究
- 転移性癌19件の研究
- 前立腺がん15件の研究
- 卵巣がん15件の研究
- 肺がん15件の研究
- 頭頸部扁平上皮癌13件の研究
- 心不全11件の研究
- 子宮内膜がん10件の研究
- 胃癌9件の研究
- 膵臓がん9件の研究
ClinicalTrials.govより、2026/10/07時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。